Investors

OvaScience is a global fertility company dedicated to improving treatment options for women around the world.

OVAS (Common Stock)
Price & Exchange
$1.09
NASDAQ
Change (%)
 Stock is Down 0.01 (0.91%)
Volume
266,758
01/19/18      4:00 p.m. ET

Minimum 20 minute delay
Refresh quote

2018 News Releases

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
DateTitle 
01/04/18OvaScience to Present at the 36th Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass.--(BUSINESS WIRE)--Jan. 4, 2018-- OvaScience℠ (NASDAQ: OVAS), a company focused on the discovery, development and commercialization of new treatment options for women and families struggling with infertility, today announced that Christopher Kroeger, M.D., Chief Executive Officer of OvaScience, will present a corporate overview at the 36th Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2018 at 11:00 a.m. PT (2:00 p.m. ET)... 
Printer Friendly Version
01/03/18OvaScienceSM Announces Corporate Update
– Reporting Safety Data from First 20 Patients in Phase 1 Study of the OvaPrimeSM Treatment; Advancing OvaPrime into Phase 1b/2a Multi-Center Trial – – James Lillie, Ph.D., Joining as Chief Scientific Officer to Lead Ongoing Preclinical Research & Development Efforts – – Improving Financial Position Through Corporate Restructuring – WALTHAM, Mass.--(BUSINESS WIRE)--Jan. 3, 2018-- OvaScience (NASDAQ:OVAS), a company focused ... 
Printer Friendly Version